Patent ID: 8853391

Claim:
A compound according to Formula I wherein: R is H; halo; CN; NO 2 ; C 1 -C 6 alkyl; CF 3 ; aryl; heteroaryl; aralkyl; alkaryl; heteroalkyl; carbocycle; C(═O)OR′; alkyl-C(═O)—; aryl-C(═O); —C(═O)aryl; —C(═O)heteroaryl; —C(═O)NH-aryl; —C(═O)NH-heteroaryl; aryl-C(═O)—; heteroaryl-C(═O); OR′; R′—SO 2 —; SO 2 —R′; SR′; R′—NH—C(═O)—; alkyl-O—C(═O)—; R′-alkyl-; R′—C(═O); or NR′R′; aryl-NH—C(═O)—; aryl-C(═O)—; OR′; R′—SO 2 —; SO 2 —R′; SR′; R′—NH—C(═O)—; alkyl-O—C(═O)—; R′-alkyl-; R′—C(═O); or NR′R′; R′ is H; O; S; CONH2; alkyl; haloalkyl; alkylhalo; haloaryl; haloheteroaryl, cycloalkyl; aryl; heteroaryl; heteroalkyl; or heteroaryl; Y is a) aryl-C(═O)—NH—NH-aryl-NH and aryl is phenyl, or b) Y is R′—NH or R′; denotes the presence or absence of a double bond; aryl, heteroaryl, heteroalkyl or cycloalkyl optionally may be substituted or unsubstituted, and may be a mono-, bi- or tricyclic ring structure in any combination of aryl, heteroaryl, heteroalkyl and/or cycloalkyl rings; and a pharmaceutically acceptable salt, tautomer and stereoisomer thereof, including mixtures thereof in all ratios.